WGCNA-ML-MR integration: uncovering immune-related genes in prostate cancer
Our study reveals that SLC14A1, ARHGEF38, NEFH, MSMB, KRT23, and KRT15 are potential diagnostic biomarkers for prostate cancer, among which MSMB may play a protective role in prostate cancer.
Authors
- Yang Shen (ORCID: https://orcid.org/0000-0002-3313-5062)
- Chaowei Fu (ORCID: https://orcid.org/0000-0003-0966-8552)
- Jing Lv
- Yuwei Zhang (ORCID: https://orcid.org/0000-0002-8395-3020)
- Bo Liu (ORCID: https://orcid.org/0000-0002-2393-117X)
- Shengkai Jin
- Yuhua Zhou (ORCID: https://orcid.org/0009-0005-4490-804X)
- Ninghan Feng
- Menglu Li
Institutions
- Jiangnan University (CN)
- Nantong University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.3389/fonc.2025.1534612
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- National Natural Science Foundation of China